Literature DB >> 31306293

ENHANCED S-CONE SYNDROME: VISUAL FUNCTION, CROSS-SECTIONAL IMAGING, AND CELLULAR STRUCTURE WITH ADAPTIVE OPTICS OPHTHALMOSCOPY.

Michael J Ammar1, Kurt T Scavelli1, Katherine E Uyhazi1, Emma C Bedoukian2, Leona W Serrano1, Ilaina D Edelstein1, Grace Vergilio1, Robert F Cooper1, Jessica I W Morgan1,3, Priyanka Kumar2, Tomas S Aleman1,2,3.   

Abstract

PURPOSE: To describe in detail the phenotype of a patient with enhanced S-cone syndrome.
METHODS: We describe a 13-year-old boy who presented with blurred vision, vitreous cells, cystoid macular edema refractory to steroid treatment, and a negative uveitic workup. The patient underwent a complete ophthalmic examination, full-field electroretinograms (ffERG), automatic static perimetry and multimodal imaging with spectral domain optical coherence tomography, and adaptive optics scanning laser ophthalmoscopy (AOSLO).
RESULTS: Spectral domain optical coherence tomography demonstrated cystoid macular edema and a hyperthick, delaminated midperipheral retina. Fluorescein angiography did not demonstrate macular leakage. Rod-mediated ffERGs were undetectable, and there was a supernormal response to short-wavelength stimuli compared with photopically matched longer wavelengths of light consistent with enhanced S-cone syndrome. Gene screening was positive for compound heterozygous mutations NR2E3: a known (c.119-2 A>C) and a novel (c.119-1G>A) mutation. By perimetry, sensitivities were normal or above normal for short-wavelength stimuli; there was no detectable rod-mediated vision. AOSLO demonstrated higher than normal cone densities in the perifoveal retina and evidence for smaller outer segment cone diameters.
CONCLUSION: Evidence for supernumerary cones (at least twice the normal complement) by AOSLO and spectral domain optical coherence tomography was associated with supernormal S-cone sensitivities and electroretinogram responses confirming previous in vivo findings in postmortem human specimens. Smaller than normal cones in enhanced S-cone syndrome may represent "hybrid" photoreceptors analogous to the rd7/rd7 murine model of the disease.

Entities:  

Mesh:

Year:  2021        PMID: 31306293      PMCID: PMC6980308          DOI: 10.1097/ICB.0000000000000891

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  28 in total

1.  Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model.

Authors:  Tomas S Aleman; Artur V Cideciyan; Geoffrey K Aguirre; Wei Chieh Huang; Cristina L Mullins; Alejandro J Roman; Alexander Sumaroka; Melani B Olivares; Frank F Tsai; Sharon B Schwartz; Luk H Vandenberghe; Maria P Limberis; Edwin M Stone; Peter Bell; James M Wilson; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

2.  Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations.

Authors:  J R Heckenlively; N Aptsiauri; S Nusinowitz; C Peng; P A Hargrave
Journal:  Trans Am Ophthalmol Soc       Date:  1996

3.  Cone Vision Changes in the Enhanced S-Cone Syndrome Caused by NR2E3 Gene Mutations.

Authors:  Alexandra V Garafalo; Giacomo Calzetti; Artur V Cideciyan; Alejandro J Roman; Supna Saxena; Alexander Sumaroka; Windy Choi; Alan F Wright; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-07-02       Impact factor: 4.799

4.  Nuclear receptor NR2E3 gene mutations distort human retinal laminar architecture and cause an unusual degeneration.

Authors:  Samuel G Jacobson; Alexander Sumaroka; Tomas S Aleman; Artur V Cideciyan; Sharon B Schwartz; Alejandro J Roman; Roderick R McInnes; Val C Sheffield; Edwin M Stone; Anand Swaroop; Alan F Wright
Journal:  Hum Mol Genet       Date:  2004-06-30       Impact factor: 6.150

5.  Phenotypic variation in enhanced S-cone syndrome.

Authors:  Isabelle Audo; Michel Michaelides; Anthony G Robson; Marko Hawlina; Veronika Vaclavik; Jennifer M Sandbach; Magella M Neveu; Chris R Hogg; David M Hunt; Anthony T Moore; Alan C Bird; Andrew R Webster; Graham E Holder
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

6.  Expanded clinical spectrum of enhanced S-cone syndrome.

Authors:  Suzanne Yzer; Irene Barbazetto; Rando Allikmets; Mary J van Schooneveld; Arthur Bergen; Stephen H Tsang; Samuel G Jacobson; Lawrence A Yannuzzi
Journal:  JAMA Ophthalmol       Date:  2013-10       Impact factor: 7.389

7.  Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity.

Authors:  M F Marmor; S G Jacobson; M H Foerster; U Kellner; R G Weleber
Journal:  Am J Ophthalmol       Date:  1990-08-15       Impact factor: 5.258

8.  Clinical and molecular characterization of enhanced S-cone syndrome in children.

Authors:  Sarah Hull; Gavin Arno; Panagiotis I Sergouniotis; Peter Tiffin; Arundhati Dev Borman; Aman Chandra; Anthony G Robson; Graham E Holder; Andrew R Webster; Anthony T Moore
Journal:  JAMA Ophthalmol       Date:  2014-11       Impact factor: 7.389

9.  Correction: Littink, K. W.; et al. Autosomal Recessive NRL Mutations in Patients with Enhanced S-Cone Syndrome. Genes 2018, 9, 68.

Authors:  Karin W Littink; Patricia T Y Stappers; Frans C C Riemslag; Herman E Talsma; Maria M van Genderen; Frans P M Cremers; Rob W J Collin; L Ingeborgh van den Born
Journal:  Genes (Basel)       Date:  2018-03-07       Impact factor: 4.096

10.  Characterizing the Human Cone Photoreceptor Mosaic via Dynamic Photopigment Densitometry.

Authors:  Ramkumar Sabesan; Heidi Hofer; Austin Roorda
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

View more
  2 in total

1.  Novel Pathogenic Sequence Variants in NR2E3 and Clinical Findings in Three Patients.

Authors:  Saoud Al-Khuzaei; Suzanne Broadgate; Stephanie Halford; Jasleen K Jolly; Morag Shanks; Penny Clouston; Susan M Downes
Journal:  Genes (Basel)       Date:  2020-10-29       Impact factor: 4.096

2.  Bardet-Biedl syndrome-7 (BBS7) shows treatment potential and a cone-rod dystrophy phenotype that recapitulates the non-human primate model.

Authors:  Tomas S Aleman; Erin C O'Neil; Keli O'Connor; Yu You Jiang; Isabella A Aleman; Jean Bennett; Jessica I W Morgan; Brian W Toussaint
Journal:  Ophthalmic Genet       Date:  2021-03-17       Impact factor: 1.274

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.